The automatic paper dispensers are set up considering male and female height difference in every toilet within the park. [Photo: Beijing Evening News and The Beijing News]

Automatic toilet paper dispensers using face detection technique are being trialed in Beijing’s Temple of Heaven Park with the aim of reducing paper use.

The park is one of the most popular tourism sites in Beijing, and has provided free paper in its public toilets for ten years but has reported seriously excessive use.

Six face detector paper dispensers have been installed in the hope of stopping the overuse.

To receive paper, you have to stand in the facial detection area and be scanned for a few seconds. The machine dispenses paper of a certain length but to get more, users have to wait for nine minutes to use the scanner again.

Personnel have been stationed to show people how to use the new system, however it still takes about half minute for each person to receive paper, way longer than using a normal dispenser.

It’s reported the machines in one of the busiest toilets are no longer in operation after people kept complaining about how long they had to wait to get paper. One staff member said the dispensers need to be adjusted to provide a better service.

It’s understood the machines will be trialed for about two weeks before going into official service depending on how they perform.

Toilet paper overuse

Paper use at the Temple of Heaven had already been decreased by 8% and 14% relatively in the last two years despite growing numbers of tourists over the same period.

However, it’s claimed, some people still lack paper use manners. According to a toilet cleaner at the Temple of Heaven, some people take much more paper than needed and sometimes even take a whole roll away with them; sometimes paper is used up in only twenty minutes.

The manager of the Temple of Heaven Park said the paper has been overused mainly by residents who live around the neighborhood instead of tourists; some people intentionally take paper here for their daily use because it’s free of charge.

Face detection dispensers are being used in the hope of preventing such a phenomenon.

Some other parks in Beijing have installed automatic toilet paper dispensers and held promotional campaigns in an effort to save paper. Taoranting Park, for example has seen paper use drop from approximately 30,000 rolls per year in 2011 to around 20,000 rolls per year today.

China has recruited a team of specialists in traditional Chinese medicine, including China’s first Nobel laureate in medicine, Tu Youyou, to help find solutions to the rising threat of antimicrobial resistance.

AMR happens when microbes evolve to become resistant to previously effective medicines. Studies show the growth in resistance could be responsible for 10 million deaths a year worldwide by 2050, according to the Review on AMR, a global report commissioned by the British government.

Antimicrobials are medicines active against a range of infections, such as those caused by bacteria (antibiotics), viruses (antivirals), fungi (antifungals) and parasites (including antimalarials), the report explains.

Western medicine is struggling to combat the problem, while the overuse of antibiotics and other antimicrobials is worsening the situation, said Cao Hongxin, head of science and technology at the State Administration of Traditional Chinese Medicine.

He said the Chinese team, led by Wang Guoqiang, vice-minister of the National Health and Family Planning Commission, will look into how TCM can be used as part of a comprehensive and dynamic approach to halt the progress of AMR.

“Traditional Chinese remedies are free from drug resistance and could provide alternative solutions,” Cao said, adding that TCM works to kill harmful microbes, reduce their replication, as well as to enhance immunity.

Tu Youyou, the pharmacologist who won the Nobel Prize in 2015, discovered artemisinin, an antimalarial drug derived from sweet wormwood, which has been used in TCM since ancient times. She has worked with China’s top TCM research institute for decades.

Huang Liuyu, director of the People’s Liberation Army’s Institute for Disease Prevention and Control, praised the efforts to develop more TCM remedies that work on infections. “TCM substitutes can lower the use of antibiotics and thereby delay the development of antibiotic-resistant microorganisms,” he said.

Traditional treatments are more complicated in terms of ingredients and are less likely to develop drug resistance, he said, although he added, “It’s usually antibiotics from Western medicine that work stronger and faster in curbing bacteria without drug resistance.”

Huang said AMR occurs naturally over the time through genetic mutations but overuse of antimicrobials speeds up the process.

Half of the antibiotics used worldwide each year are used in China, with 52 percent of that used to treat livestock, according to the Review on AMR.

PM congratulates the new UP government sworn-in today

Speech of Prime Minister (by Video conference) at the International Diamond Conference “Mines to Market 2017” on 19th March 2017

Researchers in China have discovered that a drug used to treat diabetes could be effective against a form of deadly breast cancer.

More than 70,000 people die from breast cancer in China every year, according to the national cancer center.

Triple-negative breast cancer is particularly aggressive among the four clinical subtypes of breast cancer, said Dong Chenfang, a professor at Zhejiang University School of Medicine. It has a tendency to quickly spread or metastasize to the brain and lungs. There are currently no effective targeted therapies for this form of breast cancer, which is therefore often fatal, according to Dong.8 Dong and his colleagues found that the levels of a metabolic enzyme called AKR1B1 were significantly elevated in triple-negative breast cancer cells and that this was associated with increased rates of metastasis and shorter survival times.

The researchers also found epalrestat, a drug that inhibits AKR1B1 and is approved in Japan to treat diabetic complications, was able to block the growth and metastasis of the cancer cells.

Dong said the finding is still in the experimental stage. Whether epalrestat can be applied to the clinical treatment still needs further tests.

A detailed research article was published on March 7 in the Journal of Experimental Medicine.